Chemical Compound

Levofloxacin; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (-)-Ofloxacin; (S)-(-)-Ofloxacin; (S)-Ofloxacin; Cravit; DR 3355; HR 355; Levaquin; Quixin; RWJ 25213-097; Tavanic

Name: Levofloxacin; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (-)-Ofloxacin; (S)-(-)-Ofloxacin; (S)-Ofloxacin; Cravit; DR 3355; HR 355; Levaquin; Quixin; RWJ 25213-097; Tavanic
Brand: EASY CDMO
SKU: 149096

CAS Registry Number 100986-85-4

返回搜索申请报价

Primary record

Levofloxacin; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (-)-Ofloxacin; (S)-(-)-Ofloxacin; (S)-Ofloxacin; Cravit; DR 3355; HR 355; Levaquin; Quixin; RWJ 25213-097; Tavanic

库存: 7,425 克
纯度: 98.9 %
CAS: 100986-85-4

化合物标识与属性

CAS: 100986-85-4
PubChem CID: 149096
SMILES: C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
Canonical SMILES: C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23

名称与同义词

LEVOFLOXACIN
Levaquin
Quixin
Iquix
Cravit
(-)-Ofloxacin
Levofloxacine
Tavanic
Levofloxacino
Levofloxacinum
Elequine
Oftaquix
(S)-Ofloxacin
L-Ofloxacin
Floxacin
100986-85-4
ofloxacin
Ofloxacin S-(-)-form
Volequin
Nofaxin
Levofloxacin Anhydrous
Aeroquin
Leroxacin
Levokacin
Levoxacin
Mosardal
Quinsair
Unibiotic
Lesacin
Reskuin
Venaxan
Floxel
Levox
Loxof
d-Levofloxacin
R-Ofloxacin
lLevofloxacin
Levofiexacin
Ofloxcacin
Cravit Ophthalmic
Evoxil
Floxin
S-ofloxacin
(S)-(-)-Ofloxacin
Levo Floxacin
Not Available
Levofloxacin Hemihydrate
Levaquin (TN)
Levofloxacin hydrate
(R)-isomer
Cravit IV
Cravit (TN)
Levofloxacin (INN)
S-(-)-Ofloxacin
FLUOROQUINOLONE
Anhydrous Ofloxacin
Levofloxacin (Levaquin)
LevofloxacinLevaquin
Oftaquix (TN)
Tavanic (TN)
Ofloxacin, (s)-
Anhydrous, Levofloxacin
Quixin (TN)
Levofloxacine [INN-French]
Levofloxacinum [INN-Latin]
LVFX
Iquix (TN)
Levofloxacino [INN-Spanish]
Ofloxacin S-(-)-
RefChem:5945
Spectrum_001719
DR-3355
Levofloxacin (Standard)
Levofloxacin [USAN:INN:JAN]
Levofloxacin (anhydrous)
Ofloxacin, (S)-Isomer
CHEMBL33
Levofloxacine (anhydrous)
Levofloxacino (anhydrous)
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
CCRIS 4074
RIX4E89Y14
UNII-RIX4E89Y14
6GNT3Y5LMF
DR3355
DTXSID0041060
HR 355
LEVOFLOXACIN [INN]
MFCD00865049
C18H20FN3O4
D02RSN
AC1L3YF8
GSDSWSVVBLHKDQ-JTQLQIEISA-N
Levofloxacin in 5% Dextrose
MP-376
RWJ-25213
SCHEMBL15397
BSPBio_002689
KBioGR_001605
KBioSS_002199
Levofloxacin; sodium chloride
CHEBI:63598
HSDB 8028
Levofloxacin (as hemihydrate)
MLS000759524
MLS001165709
MLS001423977
LEVOFLOXACIN [WHO-DD]
NSC-758709
SPECTRUM1504260
SPBio_001891
RWJ 25213-097
(-)-OFLX
CCRIS 4073
orb1300652
DR-3355: L-isomer of ofloxacin
C18H20FN3O4.H2O
DRG-0129
DTXCID8021060
ERK5-3D10
GTPL10911
HY-B0330R
KBio2_002199
KBio2_004767
KBio2_007335
KBio3_001909
EBD8264
J01MA12
MSK5725
S01AE05
HR-355
MMV687798
MP 376
Ofloxacin s-(-)-form hemihydrate
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HMS2232G06
Pharmakon1600-01504260
ZINC538273
DR 3354
EX-A1488
HY-B0330
Levofloxacin, 98% - 25G 25g
Levofloxacin, >=98.0% (HPLC)
BDBM50366826
C18-H20-F-N3-O4
CCG-39093
CID149096
DE-108
EBC-11226
MSK5725-100D
MSK5725-100M
NSC755604
NSC758709
s1940
CPD000466387
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
OFLOXACIN S-(-)-FORM [MI]
AKOS008901361
AKOS015895104
AC-7593
ACN-038325
AL10796
AN-8873
CID:149096
CS-2218
CS-O-01741
DB01137
NC00094
NSC 758709
NSC-755604
(S)-(-)-Ofloxacin-d3(N-methyl-d3)
NCGC00178529-01
NCGC00178529-02
NCGC00178529-03
NCGC00178529-06
AJ-23383
AS-31796
Levofloxacin tablet, suspension or intravenous
SAM001246758
SMR000466387
SY007392
Levofloxacin Solution in DMSO, 100ug/mL
Levofloxacin, analytical reference material
SBI-0206768.P001
SID:172125857
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (3S)-
AB0072147
AB1009501
J142.436J
LS-133260
LS-171761
A5511
B1959
L0193
Levofloxacin Solution in Methanol, 100ug/mL
NS00010154
ST24047487
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
C07660
D08120
AB00171657-12
AB00171657-13
AB00171657_14
AB00171657_15
986L854
A947940
D064704
F387019
Q424193
SR-05000001999
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
138199-71-0
SR-05000001999-1
BRD-K09471561-001-06-7
BRD-K09471561-001-18-2
tert-butyl?2-(hydroxymethyl)pyrrolidine-1-carboxylate
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Z1590790198
N0001-017012
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-
fluoro-methyl-(4-methylpiperazin-1-yl)-oxo-[?]carboxylic acid
LFX
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
LVX
Levofloxacin solution, 1.0 mg/mL in acetonitrile, certified reference material
()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1;()-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate
(-)-Ofloxacin; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.0^(5,13))trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo(7.3.1.05,13)trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0^{5,13}]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(2S)-7-Fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid
(3S)-3-Methyl-9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(3S)-3alpha-Methyl-7-oxo-9-fluoro-10-(4-methylpiperazino)-2,3-dihydro-7H-1,4-oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(3s)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(3S)-9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(4-methylpiperazino)-7H-pyrido[1,2,3-de]-1,4-benzooxazine-6-carboxylic acid
(3S)-9-Fluoro-2,3-dihydro-3alpha-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(3S)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(3S)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzooxazine-6-carboxylic acid
(S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
[3S,(-)]-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
[3S,(-)]-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
600-146-0
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hemihydrate, (S)-
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic Acid, 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-
7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (S)-
82419-36-1
9-Fluoro-2,3-dihydro-3alpha-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
Levofloxacin; (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (-)-Ofloxacin; (S)-(-)-Ofloxacin; (S)-Ofloxacin; Cravit; DR 3355; HR 355; Levaquin; Quixin; RWJ 25213-097; Tavanic
LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid